From Wikipedia, the free encyclopedia
|This article does not cite any references or sources. (September 2008)|
|Type||Public (NASDAQ: HALO)|
|Headquarters||San Diego, California, USA|
|Key people||Gregory I. Frost, Ph.D., President & CEO|
|Revenue||$ 3,799,521 USD (2007)|
Halozyme Therapeutics, based in San Diego, California, is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets.